Description
Fulvestrant is an estrogen receptor antagonist used for the treatment of:
- HR +Ve metastatic breast cancer in the postmenopausal women with disease progression.
- HR +Ve, HER2 -Ve advanced breast cancer along with palbociclib in women with disease progression after the therapy of endocrine.